A Myc Activity Signature Predicts Poor Clinical Outcomes in Myc-Associated Cancers.
Jung M, Russell AJ, Liu B, George J, Liu PY, Liu T, DeFazio A, Bowtell DD, Oberthuer A, London WB, Fletcher JI, Haber M, Norris MD, Henderson MJ.
Jung M, et al. Among authors: norris md.
Cancer Res. 2017 Feb 15;77(4):971-981. doi: 10.1158/0008-5472.CAN-15-2906. Epub 2016 Dec 6.
Cancer Res. 2017.
PMID: 27923830